# GRI Bio, Inc.: Form 8-K, filed Jan 8, 2026

- Company: [GRI Bio, Inc.](/companies/gri.md) (CIK 1824293)
- Form: 8-K
- Filed: 2026-01-08
- Accepted by EDGAR: Jan 8, 2026, 08:01 ET
- Period: 2026-01-08
- Accession: 0001824293-26-000002
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1824293/000182429326000002/val-20260108.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1824293/000182429326000002/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1824293/000182429326000002/val-20260108.htm

Filed Jan 8, 2026.
Source: SEC EDGAR, the filing index for accession 0001824293-26-000002. Last ingested by Listed: Nov 4, 2026, 19:21 ET. No prices; not investment advice.